A protective enzyme could help stop fatty liver disease from getting worse, according to findings the article credits to ScienceDaily.

Researchers in the United States are working on experimental therapies for metabolic and liver conditions.

The piece says halting hepatic disease remains a priority as metabolic disorders rise.

Experimental compounds are described as targeting several drivers of liver damage at once.

Laboratory models show promising results on liver inflammation, the article says.

Researchers want to reverse severe cell damage before it becomes permanent.

The enzyme could limit dangerous fat buildup, and regulators will review coming trial data.

Read the full article on the enzyme research aimed at fatty liver disease.